Systemic adeno-associated virus-mediated gene therapy preserves retinal ganglion cells and visual function in DBA/2J glaucomatous mice

Human Gene Therapy

Volumn 22, Issue 10, 2011, Pages 1191-1200

  Sullivan, Timothy A ^a   Geisert, Eldon E ^a   Hines Beard, Jessica ^a   Rex, Tonia S ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; ERYTHROPOIETIN;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; EVOKED VISUAL RESPONSE; GENE THERAPY; GLAUCOMA; HEMATOCRIT; MOUSE; NERVE CELL NECROSIS; NERVE CELL NETWORK; NEUROPROTECTION; NONHUMAN; OPTIC NERVE; OPTIC NERVE LESION; RETINA GANGLION CELL; VIRAL GENE THERAPY; VIRUS RECOMBINANT; VISION;

ANALYSIS OF VARIANCE; ANIMALS; AXONS; DEPENDOVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN; EVOKED POTENTIALS, VISUAL; GENE THERAPY; GENETIC VECTORS; GLAUCOMA; HEMATOCRIT; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAMUSCULAR; MACACA MULATTA; MICE; MICE, INBRED DBA; MUTATION, MISSENSE; OPTIC NERVE; RETINAL GANGLION CELLS; VISION, OCULAR;

ADENO-ASSOCIATED VIRUS; MUS;

EID: 80055093372     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2011.052     Document Type: Article

References (60)

1. Baltmr, A., Duggan, J., Nizari, S., et al. (2010). Neuroprotection in glaucoma: Is there a future role?. Exp. Eye Res. 91, 554-566.
2. Bayer, A.U., Ferrari, F., and Erb, C. (2002). High occurrence rate of glaucoma among patients with Alzheimer's disease. Eur. Neurol. 47, 165-168. (Pubitemid 34253039)
3. Beirowski, B., Babetto, E., Coleman, M.P., and Martin, K.R. (2008). The WldS gene delays axonal but not somatic degeneration in a rat glaucoma model. Eur. J. Neurosci. 28, 1166-1179.
4. Berdahl, J.P., Allingham, R.R., and Johnson, D.H. (2008). Cerebrospinal fluid pressure is decreased in primary open-angle glaucoma. Ophthalmology 115, 763-768. (Pubitemid 351602306)
5. Berdahl, J.P., Ethier, C.R., and Allingham, R.R. (2009). Cerebrospinal fluid pressure and glaucomatous optic disc cupping. Graefes Arch. Clin. Exp. Ophthalmol. 247, 1289-1290.
6. Brines, M.L., Ghezzi, P., Keenan, S., et al. (2000). Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. U.S.A. 97, 10526-10531.
7. Buckingham, B.P., Inman, D.M., Lambert, W., et al. (2008). Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J. Neurosci. 28, 2735-2744. (Pubitemid 351398885)
8. Campana, W.M., Li, X., Shubayev, V.I., et al. (2006). Erythropoietin reduces Schwann cell TNF-a, Wallerian degeneration and pain-related behaviors after peripheral nerve injury. Eur. J. Neurosci. 23, 617-626.
9. Canola, K., Angeánieux, B., Tekaya, M., et al. (2007). Retinal stem cells transplanted into models of late stages of retinitis pigmentosa preferentially adopt a glial or a retinal ganglion cell fate. Invest. Ophthalmol. Vis. Sci. 48, 446-454. (Pubitemid 47251436)
10. Coleman, M.P., and Perry, V.H. (2002). Axon pathology in neurological disease: A neglected therapeutic target. Trends Neurosci. 25, 532-537. (Pubitemid 35246324)
11. Digicaylioglu, M., and Lipton, S.A. (2001). Erythropoietinmediated neuroprotection involves cross-talk between Jak2 and NF-jB signalling cascades. Nature 412, 641-647. (Pubitemid 32772276)
12. Dijk, F., Bergen, A.A., and Kamphuis, W. (2007). GAP-43 expression is upregulated in retinal ganglion cells after ischemia/reperfusion-induced damage. Exp. Eye Res. 84, 858-867. (Pubitemid 46590127)
13. Ehrenreich, H., Degner, D., Meller, J., et al. (2004). Erythropoietin: A candidate compound for neuroprotection in schizophrenia. Mol. Psychiatry 9, 42-54. (Pubitemid 38175081)
14. Filippopoulos, T., Matsubara, A., Danias, J., et al. (2006). Predictability and limitations of non-invasive murine tonometry: Comparison of two devices. Exp. Eye Res. 83, 194-201. (Pubitemid 43783229)
15. Golde, W.T., Gollobin, P., and Rodriguez, L.L. (2005). A rapid, simple, and humane method for submandibular bleeding of mice using a lancet. Lab. Anim. 34, 39-43. (Pubitemid 44662092)
16. Grimm, C., Wenzel, A., Groszer, M., et al. (2002). HIF-1-induced erythropoietin in the hypoxic retina protects against lightinduced retinal degeneration. Nat. Med. 8, 718-724. (Pubitemid 34778725)
17. Grimm, C., Wenzel, A., Stanescu, D., et al. (2004). Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J. Neurosci. 24, 5651-5658. (Pubitemid 38857219)
18. Gunnarson, E., Zelenina, M., Axehult, G., et al. (2008). Identification of a molecular target for glutamate regulation of astrocyte water permeability. Glia 56, 587-596.
19. Gunnarson, E., Song, Y., Kowalewski, J.M., et al. (2009). Erythropoietin modulation of astrocyte water permeability as a component of neuroprotection. Proc. Natl. Acad. Sci. U.S.A. 106, 1602-1607.
20. Hara, K., Harris, R.A. (2002). The anesthetic mechanism of urethane: The effects on neurotransmitter-gated ion channels. Anesth. Analg. 94, 313-318. (Pubitemid 34106820)
21. Heiduschka, P., Fischer, D., and Thanos, S. (2005). Recovery of visual evoked potentials after regeneration of cut retinal ganglion cell axons within the ascending visual pathway in adult rats. Restor. Neurol. Neurosci. 23, 303-312. (Pubitemid 41746164)
22. Heiduschka, P., Julien, S., Schuettauf, F., and Schnichels, S. (2010). Loss of retinal function in aged DBA/2J mice: New insights into retinal neurodegeneration. Exp. Eye Res. 91, 779-783.
23. Hernandez, M.R., Miao, H., and Lukas, T. (2008). Astrocytes in glaucomatous optic neuropathy. Prog. Brain Res. 173, 353-373.
24. Holder, G.E. (2004). Electrophysiological assessment of optic nerve disease. Eye (Lond) 18, 1133-1143. (Pubitemid 39591796)
25. Howell, G.R., Libby, R.T., Jakobs, T.C., et al. (2007). Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J. Cell Biol. 179, 1523-1537.
26. Inman, D.M., and Horner, P.J. (2007). Reactive nonproliferative gliosis predominates in a chronic mouse model of glaucoma. Glia 55, 942-953. (Pubitemid 46903995)
27. John, S.W., Smith, R.S., Savinova, O.V., et al. (1998). Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest. Ophthalmol. Vis. Sci. 39, 951-962. (Pubitemid 28196680)
28. Junk, A.K., Mammis, A., Savitz, S.I., et al. (2002). Erythropoietin administration protects retinal neurons from acute ischemiareperfusion injury. Proc. Natl. Acad. Sci. U.S.A. 99, 10659-10664.
29. Keswani, S.C., Buldanlioglu, U., Fischer, A., et al. (2004). A novel endogenous erythropoietin mediated pathway prevents axonal degeneration. Ann. Neurol. 56, 815-826. (Pubitemid 39578445)
30. Konishi, Y., Chui, D.H., Hirose, H., et al. (1993). Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res. 609, 29-35. (Pubitemid 23136796)
31. Libby, R.T., Anderson, M.G., Pang, I.H., et al. (2005). Inherited glaucoma in DBA/2J mice: Pertinent disease features for studying the neurodegeneration. Vis. Neurosci. 22, 637-648. (Pubitemid 43237759)
32. Lin, X., Fujita, M., Kanemitsu, N., et al. (2007). Sustained-release erythropoietin ameliorates cardiac function in infarcted ratheart without inducing polycythemia. Circ. J. 71, 132-137. (Pubitemid 46049735)
33. McKinnon, S.J. (2003). Glaucoma: Ocular Alzheimer's disease?. Front. Biosci. 8, 1140-1156.
34. Mennini, T., De Paola, M., Bigini, P., et al. (2006). Nonhematopoietic erythropoietin derivatives prevent motoneuron degeneration in vitro and in vivo. Mol. Med. 12, 153-160. (Pubitemid 44646344)
35. Nagaraju, M., Saleh, M., and Porciatti, V. (2007). IOP-dependent retinal ganglion cell dysfunction in glaucomatous DBA/2J mice. Invest. Ophthalmol. Vis. Sci. 48, 4573-4579. (Pubitemid 351260974)
36. Neufeld, A.H., Hernandez, M.R., and Gonzalez, M. (1997). Nitric oxide synthase in the human glaucomatous optic nerve head. Arch. Ophthalmol. 115, 497-503. (Pubitemid 27172706)
37. Neufeld, A.H., Sawada, A., and Becker, B. (1999). Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc. Natl. Acad. Sci. U.S.A. 96, 9944-9948. (Pubitemid 29398837)
38. Qu, J., Wang, D., and Grosskreutz, C.L. (2010). Mechanisms of retinal ganglion cell injury and defense in glaucoma. Exp. Eye Res. 91, 48-53.
39. Quigley, H.A., and Broman, A.T. (2006). The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 90, 262-267. (Pubitemid 43325451)
40. Raff, M.C., Whitmore, A.V., and Finn, J.T. (2002). Axonal self-destruction and neurodegeneration. Science 296, 868-871.
41. Rex, T.S., Wong, Y., Kodali, K., and Merry, S. (2009). Neuroprotection of photoreceptors by direct delivery of erythropoietin to the retina of the retinal degeneration slow mouse. Exp. Eye Res. 89, 735-740.
42. Rivera, V.M., Gao, G.P., Grant, R.L., et al. (2005). Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer. Blood 105, 1424-1430. (Pubitemid 40223657)
43. Ruscher, K., Freyer, D., Karsch, M., et al. (2002). Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: Evidence from an in vitro model. J. Neurosci. 22, 10291-10301. (Pubitemid 35416867)
44. Sabel, B.A., and Aschoff, A. (1993). Functional recovery and morphological changes after injury to the optic nerve. Neuropsychobiology 28, 62-65. (Pubitemid 23283752)
45. Sakanaka, M., Wen, T.C., Matsuda, S., et al. (1998). In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. U.S.A. 95, 4635-4640. (Pubitemid 28207965)
46. Savinova, O.V., Sugiyama, F., Martin, J.E., et al. (2001). Intraocular pressure in genetically distinct mice: An update and strain survey. BMC Genet. 2, 16.
47. Scheerer, N., Duänker, N., Imagawa, S., et al. (2010). The anemia of the newborn induces erythropoietin expression in the developing mouse retina. Am. J. Physiol. Regul. Integr. Comp. Physiol. 299, R111-R118.
48. Sena, D.F., Ramchand, K., and Lindsley, K. (2010). Neuroprotection for treatment of glaucoma in adults. Cochrane Database Syst. Rev. 2, CD006539.
49. Shah, S.S., Tsang, S.H., and Mahajan, V.B. (2009). Erythropoietin receptor expression in the human diabetic retina. BMC Res. Notes 2, 234.
50. Son, J.L., Soto, I., Oglesby, E., et al. (2010). Glaucomatous optic nerve injury involves early astrocyte reactivity and late oligodendrocyte loss. Glia 58, 780-789.
51. Sullivan, T., Kodali, K., and Rex, T.S. (2011). Systemic gene delivery protects the photoreceptors in the retinal degeneration slow mouse. Neurochem. Res. 36, 613-618.
52. van der Kooij, M.A., Groenendaal, F., Kavelaars, A., et al. (2008). Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ ischemia. Brain Res. Rev. 59, 22-33.
53. Wang, H., Liu, Z.L., Zhuang, X.T., et al. (2009). Neuroprotective effect of recombinant human erythropoietin on optic nerve injury in rats. Chin. Med. J. (Engl) 122, 2008-2012.
54. Wang, W.H., Millar, J.C., Pang, I.H., et al. (2005). Noninvasive measurement of rodent intraocular pressure with a rebound tonometer. Invest. Ophthalmol. Vis. Sci. 46, 4617-4621. (Pubitemid 44264562)
55. Wish, J.B. (2009). Past, present, and future of chronic kidney disease anemia management in the United States. Adv. Chronic Kidney Dis. 16, 101-108.
56. Yamamoto, M., Koshimura, K., Sohmiya, M., et al. (2004). Effect of erythropoietin on nitric oxide production in the rat hippocampus using in vivo brain microdialysis. Neuroscience 128, 163-168. (Pubitemid 39140689)
57. Yamasaki, M., Mishima, H.K., Yamashita, H., et al. (2005). Neuroprotective effects of erythropoietin on glutamate and nitric oxide toxicity in primary cultured retinal ganglion cells. Brain Res. 1050, 15-26. (Pubitemid 40922713)
58. Yang, Y., Yu, M., Zhu, J., et al. (2010). Role of cerebrospinal fluid in glaucoma: Pressure and beyond. Med. Hypotheses 74, 31-34.
59. Yin, Z.S., Zhang, H., Bo, W., and Gao, W. (2010). Erythropoietin promotes functional recovery and enhances nerve regeneration after peripheral nerve injury in rats. Am. J. Neuroradiol. 31, 509-515.
60. Zhong, L., Bradley, J., Schubert, W., et al. (2007). Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Invest. Ophthalmol. Vis. Sci. 48, 1212-1218. (Pubitemid 351261416)